← Leaderboards
Patrick Thomas Cahalan
Ension, Inc.
$6,985,177
Attributed
$7,226,584
Total exposure
9
Grants
8
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.3M · FY2006–25$2M$1.5M$1M$500K$0
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$7,226,584 · 9
By mechanism
R44$4,981,665 · 4
R42$1,451,404 · 1
R43$793,515 · 4
Top collaborators
- Benjamin Curry1 shared
- Ali Hussain1 shared
Most similar at Ension, Inc.
Same institution · by research overlap
- Mark Gartner$9,775,449
- Philip Litwak$1,435,327
- Ali Hussain$412,318
- David L. Trumper$178,488
Others in their field
Top investigators on “In Vitro”
- David Heimbrook · Leidos Biomedical Research, Inc.$553,787,942
- Leonard Freedman · Leidos Biomedical Research, Inc.$310,441,779
- Mark S Klempner · Tufts Medical Center$128,021,180
- Florian Krammer · Icahn School Of Medicine At Mount Sinai$104,723,856
- Lynn Briscoe · Leidos Biomedical Research, Inc.$94,686,873
- Dennis R. Burton · Scripps Research Institute$79,204,175
Research focus
In VitroDesignPerformanceBloodBaseBiomaterial CompatibilityEvaluationIn VivoMechanicsBlood PlateletsLeukocytesTechnologyIn Vitro TestingPrototypeCommercializationAnimalsMedicalAreaCostSurfaceChildhoodAdultChronicGenerations
Grant awards (12)
Bearingless flux reversal motor for neonatal and pediatric extracorporeal life support applications$870,467
R44 · FY2025 · HL · contact PI
Magnetic levitation motor for pediatric cardiac and cardiopulmonary therapies - Phase II$652,543
R42 · FY2021 · HL · contact PI
Magnetic levitation motor for pediatric cardiac and cardiopulmonary therapies - Phase II$798,861
R42 · FY2020 · HL · contact PI
System and comprehensive approach for blood compatibility of medical devices and biomaterial$1,261,442
R44 · FY2019 · HL · contact PI
System and comprehensive approach for blood compatibility of medical devices and biomaterials$257,843
R43 · FY2016 · HL · contact PI
Architecturally Enhanced and Reinforced Regenerative Collagen Matrix for Wound Healing Applications$224,971
R43 · FY2015 · AR
Infection resistant surface for ventricular assist device (VAD) transcutaneous dr$880,733
R44 · FY2014 · HL · contact PI
Infection resistant surface for ventricular assist device (VAD) transcutaneous dr$391,529
R44 · FY2013 · HL · contact PI
Biocompatible Coating for Pediatric Blood Oxygenators - Phase II$885,947
R44 · FY2009 · HL · contact PI
Infection resistent coatings for mechanical circulatory support systems (MCSS)$157,723
R43 · FY2009 · HL · contact PI
Biocompatible Coating for Pediatric Blood Oxygenators - Phase II$691,547
R44 · FY2008 · HL · contact PI
Biocompatible Coating for Pediatric Blood Oxygenators$152,978
R43 · FY2006 · HL · contact PI